Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is the era of personalized dosimetry in hepatic radioembolization coming to an end?

Revista espanola de medicina nuclear e imagen molecular·2026
Same author

Individual Choices of Wintering Areas Drive Adult Survival Heterogeneity in a Long-Lived Seabird.

Ecology and evolution·2024
Same author

Assessment of pulmonary nodules using [<sup>18</sup>F]-FDG PET/CT in deep inspiration breath-hold.

Revista espanola de medicina nuclear e imagen molecular·2024
Same author

Investigation of screening questions to identify insomnia in cancer patients.

Scientific reports·2024
Same author

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study.

Revista espanola de anestesiologia y reanimacion·2024
Same journal

Integration of Nuclear Medicine in Multidisciplinary Committees: Involvement, perception, and areas for improvement. Results of a national survey.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Prediction of PD-L1 expression in gastric cancer using <sup>18</sup>F-FDG PET/CT radiomics.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Bilateral renoureteral plasmacytoma. An unusual presentation in a young patient with multiple myeloma.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

The nuclear oncologist.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Prognostic value of radionics based on <sup>18</sup>F-FDG PET/CT in Hodgkin lymphoma: A systematic review.

Revista espanola de medicina nuclear e imagen molecular·2026
Same journal

Cardiac amyloidosis: An update on nuclear cardiology in diagnosis and follow-up.

Revista espanola de medicina nuclear e imagen molecular·2026
See all related articles

Related Experiment Video

Updated: Jan 5, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K

Radioembolization in liver tumours.

L Carrion-Martin1, J Orcajo Rincón1, A Rotger1

  • 1Hospital Gregorio Marañón, España.

Revista Espanola De Medicina Nuclear E Imagen Molecular
|October 21, 2019
PubMed
Summary
This summary is machine-generated.

Transarterial Radioembolization (TARE) is an increasingly used, safe, and effective treatment for liver tumors. Proper patient selection and planning are crucial for successful outcomes and minimizing complications.

Keywords:
HepatocarcinomaMetastasesMetástasisRadioembolizaciónRadioembolization

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.0K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K

Related Experiment Videos

Last Updated: Jan 5, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.0K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.8K

Area of Science:

  • Interventional Radiology
  • Oncology
  • Hepatology

Background:

  • Malignant liver tumors often exhibit arterial vascularization, differentiating them from healthy liver parenchyma.
  • This vascular characteristic makes liver tumors particularly responsive to transarterial therapies.
  • Transarterial Radioembolization (TARE) is an evolving treatment modality for various liver malignancies.

Purpose of the Study:

  • To highlight the growing importance and efficacy of Transarterial Radioembolization (TARE) in managing liver tumors.
  • To emphasize the critical role of multidisciplinary collaboration, patient selection, and pre-procedural planning in TARE.
  • To discuss the expanding indications for TARE beyond traditional uses in hepatocellular carcinoma and liver metastases.

Main Methods:

  • TARE involves delivering targeted radiation directly to liver tumors via arterial access.
  • The procedure requires careful patient selection based on tumor characteristics and liver function.
  • Detailed arteriography is essential for optimal treatment planning and execution.

Main Results:

  • TARE has demonstrated significant improvements, establishing it as a safe and effective treatment option.
  • Effective TARE requires a multidisciplinary team approach due to its complexity.
  • Careful patient selection and arteriography planning are key to maximizing benefits and minimizing complications.

Conclusions:

  • TARE is a safe and effective treatment for liver tumors, with ongoing advancements.
  • Multidisciplinary collaboration and meticulous planning are vital for successful TARE outcomes.
  • The application of TARE is expanding, including its use as a standalone therapy or in combination treatments.